| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/13/2001 | CA2402466A1 Composition consisting of phy906 and chemotherapeutic agents |
| 09/13/2001 | CA2401889A1 Lipid carrier |
| 09/13/2001 | CA2401857A1 New self emulsifying drug delivery system |
| 09/13/2001 | CA2401239A1 Improved poloxamer and poloxamine compositions for nucleic acid delivery |
| 09/13/2001 | CA2400401A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such |
| 09/13/2001 | CA2373171A1 Stretch plaster |
| 09/13/2001 | CA2372931A1 Oleoresin of hypericum perforatum l., method for obtaining said oleoresin and the use thereof |
| 09/12/2001 | EP1132416A1 Colloidal nanoparticular carriers comprising loaded or non-loaded water soluble comb polymers and their use in mucosal applications |
| 09/12/2001 | EP1132383A1 Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine |
| 09/12/2001 | EP1132096A1 Suppositories |
| 09/12/2001 | EP1132094A1 Percutaneously administrable preparations containing cerebral function activators |
| 09/12/2001 | EP1132084A1 Transdermal device for the slow release of soybean derived vegetable estrogens |
| 09/12/2001 | EP1132081A2 Process for preparing cellulose capsule using mixed solution of pectin and glycerin |
| 09/12/2001 | EP1132080A2 Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| 09/12/2001 | EP1132065A1 Coloured visco-elastic composition |
| 09/12/2001 | EP1131344A2 Retro-inversion peptides that target git transport receptors and related methods |
| 09/12/2001 | EP1131316A2 Improved chemical process and pharmaceutical formulation |
| 09/12/2001 | EP1131104A1 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
| 09/12/2001 | EP1131103A1 Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 09/12/2001 | EP1131097A1 Anti-icam-r antibody-induced apoptosis |
| 09/12/2001 | EP1131089A1 Stable aqueous insulin preparations without phenol and cresol |
| 09/12/2001 | EP1131072A2 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide |
| 09/12/2001 | EP1131071A1 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption |
| 09/12/2001 | EP1131070A1 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 09/12/2001 | EP1131068A1 Compositions of and process for producing isotretinoin having low particle size |
| 09/12/2001 | EP1131067A1 Composition and use of rar antagonists for promoting chondrogenesis |
| 09/12/2001 | EP1131065A2 Utilisation of dialkylfumarates |
| 09/12/2001 | EP1131063A2 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 09/12/2001 | EP1131062A1 Injectable propofol formulations |
| 09/12/2001 | EP1131059A1 Dry powder for inhalation |
| 09/12/2001 | EP1131058A1 Local delivery of drugs to the colon for local treatment of colonic diseases |
| 09/12/2001 | EP1131057A1 Cushioning wax beads for making solid shaped articles |
| 09/12/2001 | EP1131056A1 Particles based on polyamino-acid(s) and methods for preparing same |
| 09/12/2001 | EP1131055A1 Treatment set containing lungsurfactant compositions |
| 09/12/2001 | EP1131054A2 Methods for preparing coated drug particles and pharmaceutical formulations thereof |
| 09/12/2001 | EP1131053A2 Nanocapsules and method of production thereof |
| 09/12/2001 | EP1131052A1 Vaginally administrable progesterone-containing tablets and method for preparing same |
| 09/12/2001 | EP1131051A1 Pressurised metered dose inhalers (mdi) |
| 09/12/2001 | EP1131050A1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 09/12/2001 | EP1131047A1 Oil bodies as topical delivery vehicles for active agents |
| 09/12/2001 | EP1131037A1 Process for the manufacture of liquid filled capsules |
| 09/12/2001 | EP1130966A1 Antiparasitic formulations |
| 09/12/2001 | EP1130964A1 Therapeutic anti-fungal nail preparation |
| 09/12/2001 | EP1007004B1 Method for preparing an extract of active principles in the form of microgranules based on dietary fibres |
| 09/12/2001 | EP0936894B1 Active agent delivery device |
| 09/12/2001 | EP0886527B1 Pharmaceutical compositions comprising natural human alpha-interferon |
| 09/12/2001 | EP0880366B1 Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-beta-estradiol to the human organism |
| 09/12/2001 | EP0809627B1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use |
| 09/12/2001 | EP0789585B1 A storage stable water solution for infusion containing a thrombin inhibitor |
| 09/12/2001 | EP0788349B1 Liposome composition containing selegilin |
| 09/12/2001 | EP0782855B1 Nimesulide for external use |
| 09/12/2001 | EP0764177B1 Crosslinked polymer containing composition for removing bile salts from a patient |
| 09/12/2001 | EP0732916B1 Viracidal, bactericidal and spermicidal vaginal suppository |
| 09/12/2001 | EP0682514B1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
| 09/12/2001 | EP0630240B1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists |
| 09/12/2001 | CN1312970A Chuck apparatus for clamping a planar substrate in an electrostatic coating method |
| 09/12/2001 | CN1312714A Pharmaceutical composition containing lipase inhibitors and chitosan |
| 09/12/2001 | CN1312713A Pharmaceutical compositions containing lipase inhibitors |
| 09/12/2001 | CN1312711A Medicinal compositions for treating evacuatory insufficiency |
| 09/12/2001 | CN1312710A Active ingredient support in the form of a film |
| 09/12/2001 | CN1312709A Pharmaceutical Product and Methods and apparatus for making same |
| 09/12/2001 | CN1312708A Process of generating submicron particles of water-insuluble compounds |
| 09/12/2001 | CN1312707A Method of forming liposomes |
| 09/12/2001 | CN1312706A Medicinal aerosol for mulations |
| 09/12/2001 | CN1312251A Preparation of partially synthesized deuteroporphyrin derivative and its freeze dried injection |
| 09/12/2001 | CN1312112A Cure-all ointment |
| 09/12/2001 | CN1312109A American ginseng buccal tablet and its preparation method |
| 09/12/2001 | CN1312100A Tumor treating ointment |
| 09/12/2001 | CN1312097A Fracture setting asafetida-musk ointment |
| 09/12/2001 | CN1312092A Rheumatism treating oral capsule and plaster and their preparation method |
| 09/12/2001 | CN1312091A Vaginitis treating medicine |
| 09/12/2001 | CN1312088A Medicine for treating obsessional neurosis via head acupoint osmosis |
| 09/12/2001 | CN1312084A Phinitis suppository for treating chronic rhinitis and its preparation method |
| 09/12/2001 | CN1312082A Leukoderma curing plaster |
| 09/12/2001 | CN1312078A Making process of compound sulfadiazine zinc spreader |
| 09/12/2001 | CN1312076A External-use and eye ofloxacin zinc preparation |
| 09/12/2001 | CN1312071A Linolic acid and linolenic acid capsule and its making process |
| 09/12/2001 | CN1312068A Caries preventing antiphlogistic oral cavity preparation |
| 09/12/2001 | CN1312065A Use of compound for improving skin and its mucous membrane physical-chemical property to prevent adsorption of microorganism |
| 09/12/2001 | CN1312033A Microcapsulized pine nut kernel powder and its making process |
| 09/12/2001 | CN1070709C Traditional Chinese medicinal preparation for treating hepatopathy and preparation method thereof |
| 09/12/2001 | CN1070703C Preparation of fusidic acid tablets |
| 09/12/2001 | CN1070699C Topical composition comprising N-acetye-L-cysteine |
| 09/12/2001 | CN1070697C Method of preparing novel microcapsule |
| 09/11/2001 | US6288137 Process for preparing an aqueous composition in gel form and compositions obtainable from this process, especially a composition containing vesicles, in particular liposomes |
| 09/11/2001 | US6288127 Adding lewis acid inhibitor |
| 09/11/2001 | US6288121 Nimesulide topical formulations in the form of liquid crystals |
| 09/11/2001 | US6288090 Pharmaceutical composition |
| 09/11/2001 | US6288087 An extract from eupatorium purpurem, cytochrome p450 inducing compound, sugar, a source of phosphate, and one or more carriers |
| 09/11/2001 | US6288080 High speed absorption in blood; nonprecipitating |
| 09/11/2001 | US6288049 Cellulose and nonionic surfactant increase redispersibility and prevent aggregation |
| 09/11/2001 | US6288043 Injectable hyaluronate-sulfated polysaccharide conjugates |
| 09/11/2001 | US6288040 Medicament excipient particles for tissue-specific application of a medicament |
| 09/11/2001 | US6288026 Administering a paravac composition as a parenteral adjuvant for reduced side effects |
| 09/11/2001 | US6288025 Protease inhibitors for use in the treatment of psoriasis |
| 09/11/2001 | US6287816 BMP-9 compositions |
| 09/11/2001 | US6287693 Stable shaped particles of crystalline organic compounds |
| 09/11/2001 | US6287606 Methods of enhancing wound healing and tissue repair |
| 09/11/2001 | US6287604 Biodegradable targetable microparticle delivery system |
| 09/11/2001 | US6287602 Treatment of oncologic tumors with an injectable formulation of a Golgi apparatus disturbing agent |